Research & Clinical Trials – Page 5
-
newsResearch & Clinical TrialsFuture treatment of pleural mesothelioma cancer continued its move toward a more personalized, targeted approach with the latest results from a multi-center clinical…
-
newsResearch & Clinical Trials
New Mesothelioma Immunotherapy Clinical Trial Opens at MD Anderson
The acclaimed MD Anderson Cancer Center in Houston is opening a phase II clinical trial involving a new immunotherapy drug aimed specifically at… -
newsResearch & Clinical Trials
Heated Intrathoracic Chemotherapy Could Extend Mesothelioma Survival
Patients with pleural mesothelioma undergoing aggressive surgery should consider combining it with controversial hyperthermic intrathoracic chemotherapy to extend survival, according to a recent… -
newsResearch & Clinical Trials
Study Finds Benefits to Second Peritoneal Mesothelioma Surgery
Patients with peritoneal mesothelioma cancer can survive considerably longer if they are willing and able to undergo a second aggressive surgery following tumor… -
newsResearch & Clinical Trials
Mesothelioma Clinical Trial Matches Treatment to Genetic Profiles
Scientists at the University of Leicester in the United Kingdom recently published phase 2 clinical trial results involving abemaciclib, a new genetic therapy for… -
newsResearch & Clinical Trials
NCI Moving Closer to More Effective Treatment for Pleural Mesothelioma
A research team at the National Cancer Institute is developing a novel therapy that could change the treatment paradigm for pleural mesothelioma. -
newsResearch & Clinical Trials
NCI Opens New Immunotherapy Clinical Trial for Mesothelioma
The National Cancer Institute has opened a promising clinical trial aimed at increasing the effectiveness of immunotherapy treatment for patients with unresectable malignant… -
newsResearch & Clinical Trials
Clinical Trials Lead to Promising Updates in Mesothelioma Immunotherapy
Researchers have made significant progress in mesothelioma treatment advancements recently, including promising work with immunotherapy. The first U.S. Food and Drug Administration-approved combination… -
newsResearch & Clinical Trials
Mesothelioma Clinical Trial to Involve Drug Studied for COVID-19
A novel phase II clinical trial for malignant mesothelioma is expected to open soon and involve a versatile, biological drug already showing promise… -
newsResearch & Clinical Trials
University of Vermont Study Opens New Door for Mesothelioma Treatment
Researchers at the University of Vermont Cancer Center have uncovered a new approach to the treatment of malignant pleural mesothelioma, sparking a…